FDA Approves Eli Lilly’s GLP-1 Pill

FDA Approves Eli Lilly’s GLP-1 Pill thumbnail

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.

LEAVE A REPLY

Your email address will not be published. Required fields are marked *